PAUL SCHIMMEL Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for PAUL SCHIMMEL.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of PAUL SCHIMMEL. PAUL SCHIMMEL is a Director in ALKERMES INC ($ALKS) and a Director in ALNYLAM PHARMACEUTICALS, INC. ($ALNY) and a Director in aTYR PHARMA INC ($LIFE) and a Director in Tocagen Inc ($TOCA).

Address: 88 SIDNEY STREET CAMBRIDGE 02139 MA

Companies in which PAUL SCHIMMEL is an Insider

ALKERMES INC

Trading Symbol: ALKS
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of PAUL SCHIMMEL: Director
Holdings: 355,600 shares
Current Value: $19,476,212
Latest Transaction: Sep 22 2006
$ALKS Market Capitalization: $8.27B
$ALKS Previous Close: $54.77

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

ALNYLAM PHARMACEUTICALS, INC.

Trading Symbol: ALNY
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of PAUL SCHIMMEL: Director
Holdings: 10,000 shares
Current Value: $404,600
Latest Transaction: Jul 02 2019
$ALNY Market Capitalization: $3.49B
$ALNY Previous Close: $40.46

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

aTYR PHARMA INC

Trading Symbol: LIFE
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of PAUL SCHIMMEL: Director
Holdings: 429,143 shares
Current Value: $1,459,086
Latest Transaction: Apr 29 2021
$LIFE Market Capitalization: $78.27M
$LIFE Previous Close: $3.40

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Forte Biosciences, Inc.

Trading Symbol: TOCA
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of PAUL SCHIMMEL: Director
Holdings: 23,464 shares
Latest Transaction: Oct 04 2019

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Latest Insider Trading Transactions of PAUL SCHIMMEL

Sentiment: All, ALKS, ALNY, LIFE, TOCA

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Apr 29 2021LIFEaTYR PHARMA INCSCHIMMEL PAULDirectorOption ExerciseA4.211,4286,0121,428
May 22 2020LIFEaTYR PHARMA INCSCHIMMEL PAULDirectorSellS3.648,44730,739429,143437.6 K to 429.1 K (-1.93 %)
May 08 2020LIFEaTYR PHARMA INCSCHIMMEL PAULDirectorOption ExerciseA3.651,4285,2121,428
Feb 11 2020LIFEaTYR PHARMA INCSCHIMMEL PAULDirectorBuyP4.25254,0001,079,500437,590183.6 K to 437.6 K (+138.35 %)
Oct 04 2019TOCATocagen IncSCHIMMEL PAULDirectorOption ExerciseA0.647,5004,7937,500
Oct 04 2019TOCATocagen IncSCHIMMEL PAULDirectorOption ExerciseA0.647,5004,7937,500
Jul 02 2019ALNYALNYLAM PHARMACEUT ...SCHIMMEL PAULDirectorOption ExerciseA72.019,000648,0909,000

View all PAUL SCHIMMEL insider transactions.